JP Morgan Maintains Overweight on Brookfield, Lowers Price Target to $64
JP Morgan analyst Kenneth Worthington maintains Brookfield (NYSE:BN) with a Overweight and lowers the price target from $65 to $64.
Brookfield Corporation (BN) Stock News
Follow the latest Brookfield Corporation (BN) news and market headlines alongside the live BN price. Stay informed on what's moving BN.
Brookfield (BN)
NYSE
$40.97
$0.67(-1.61%)
After-Hours
News
- BenzingaRead Full Article
- BenzingaRead Full Article
RBC Capital Maintains Outperform on Brookfield, Lowers Price Target to $59
RBC Capital analyst Bart Dziarski maintains Brookfield (NYSE:BN) with a Outperform and lowers the price target from $61 to $59.
- MassiveRead Full Article
Boralex annonce une première émission d’obligations vertes de 600 M$ CA
Boralex announced the issuance of $600 million CAD in medium-term green bonds across two series with maturities in 2031 and 2036, rated BBB by Morningstar DBRS. The proceeds will finance eligible green investments and refinance existing credit facilities. This marks Boralex's first corporate green bond issuance.
- MassiveRead Full Article
Boralex Announces C$600 Million Inaugural Issuance of Green Bonds
Boralex Inc. announced the issuance of C$600 million in medium-term notes through private placement, comprised of C$250 million due 2031 at 4.503% and C$350 million due 2036 at 5.173%. The inaugural green-labelled offering will fund eligible renewable energy investments and repay corporate bridge credit facilities. The notes received a BBB rating with stable trend from Morningstar DBRS.
- BenzingaRead Full Article
Brookfield Q3 Adj. EPS $0.73 Beats $0.72 Estimate, Sales $20.691B Beat $1.800B Estimate
Brookfield (TSX:BN) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. This is a 15.87 percent increase over earnings of $0.63 per share from the same
- MassiveRead Full Article
Brookfield Gears Up to Report Q3 Earnings: What's in the Cards?
Brookfield Corporation is expected to report Q3 2026 results on November 12 with EPS projected to rise 14.3% year-over-year, supported by strong fundraising, higher fee-bearing capital, and demand for infrastructure investments. However, the company faces headwinds from higher interest expenses. The Zacks quantitative model does not predict an earnings beat, with BN holding a Zacks Rank #5 (Strong Sell) despite a positive Earnings ESP of +1.86%.
- MassiveRead Full Article
2 Stocks I'd Buy Right Now and Hold Through 2035
The author recommends Brookfield Corporation and Alphabet as long-term buy-and-hold stocks through 2035. Brookfield trades near 52-week lows despite strong earnings growth and record fundraising, while Alphabet's heavy AI infrastructure spending has pressured free cash flow but its $561 billion cloud backlog and 25% revenue growth offer significant long-term potential. Both companies are investing aggressively today to build future growth, making them attractive for investors with long time horizons.
Explore More US Stocks
Stocks in the Same Sector
Browse other US stocks in the same sector as Brookfield Corporation
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Data Sources and Disclosures
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to BN, including RealStocks and Stock Futures.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.